Principles of Finance 6e Chapter 7
Besley/Brigham
distributors. Because of the poor performance of Bausch & Lomb in 1994, the CEO’s performance bonus
was cut to zero. Additional information concerning Bausch & Lomb’s decision to change its distribution
system can be found in the following articles:
“Bausch & Lomb: Clouded Vision,” Financial World, May 23, 1995, p. 16+.
“Bad Math at Bausch & Lomb?,” Business Week, December 19, 1994, p. 108+.
“Bausch & Lomb’s Myopia,” Forbes, December 5, 1994, p. 14+.
It was reported that PerSeptive would offer its diagnostic equipment, some of which cost in excess of
$50,000, to prospective customers on a trial basis, requiring payment at some later date only if the
equipment was found to be desirable. At the time, PerSeptive’s management stated the strategy was to
increase renewable sales by allowing the market to experience its product firsthand before requiring a
purchase commitment. Even though the trial offers were not technically considered sales, in some
instances, PerSeptive recorded them as sales and corresponding receivables. For the quarter ending
September 30, 1994, PerSeptive posted nearly a $21 million loss because it wrote off a large amount of
inventory and had to reduce accounts receivable significantly. Its “free trial” offer did not generate the
renewable sales that it hoped. For more information about PerSeptive and this situation, the following
articles might be helpful:
“PerSeptive Restates Its Results for Much of Past 2 Fiscal Years,” The Wall Street Journal, December 28,
1994.
“Biotech Company Is Questioned About ‘Try It Out’ Sales Strategy,” The Wall Street Journal, November 8,
1994, p. B1+.
“Enterprise: Tech Concerns Fudge Figures to Buoy Stocks,” The Wall Street Journal, May 19, 1994, p. B1+.